RE

Regeneron Pharmaceuticals $REGN

Health Care · Biotechnology · NASDAQ

S&P 500 Nasdaq-100

$654.27

+29.55 (+4.73%)

As of Jul 4, 2026, 11:40 PM EDT

Regeneron Pharmaceuticals (REGN) is trading up at $654.27 (+4.73%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Recent News (4)

Meddelelse nr. 15/2026: Indre værdi pr. 30. juni 2026 GlobeNewswire · 03 Jul 2026 Opgørelsen er baseret på samme regnskabspraksis som årsrapporten for 2025. Opgørelsen er ikke revideret. Der tages forbehold for endelig opgørelse.
Is Johnson & Johnson (JNJ) Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat? simplywall.st · 03 Jul 2026 Is Johnson & Johnson (JNJ) Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat? simplywall.st
Is Johnson & Johnson (JNJ) Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat? simplywall.st · 02 Jul 2026 Is Johnson & Johnson (JNJ) Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat? simplywall.st
Johnson & Johnson (JNJ) Reports IMAAVY Gains In Myasthenia Gravis And Pregnancy Study Plans simplywall.st · 01 Jul 2026 Johnson & Johnson (JNJ) Reports IMAAVY Gains In Myasthenia Gravis And Pregnancy Study Plans simplywall.st